Golden Flower Chinese Herbs (GFCH) has been a key player in the Health Care and Pharmaceutical industries since its establishment in 1990. The company is renowned for providing practitioners of Oriental Medicine with a comprehensive range of high-quality, traditional, and innovative herbal formulas, along with acupuncture needles and clinical supplies. GFCH serves as a one-stop destination for Chinese Medicine products, offering a diverse product line that includes 100 specially designed formulas, Spring Wind Topical Products, and over 700 granulated extracts from KPC Herbs. In addition, the company expanded its offerings to include a complete line of acupuncture supplies, ranging from needles and moxa to essential oils and electro-acupuncture devices. As of now, GFCH has not disclosed its recent investment details or participating investors, but its longstanding presence and reputation in the industry showcase its potential for further growth and investment opportunities. With its strong foothold in the niche market of traditional Chinese Medicine products and a wide range of offerings, GFCH presents an intriguing prospect for potential investors seeking exposure in the health and wellness sector.
There is no investment information
No recent news or press coverage available for Golden Flower Chinese Herbs.
We care about your data, and we'd love to use cookies make your experience better.
